A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

[1]  Lifang Yang,et al.  microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway , 2015, Journal of Cancer Research and Clinical Oncology.

[2]  Zoltan Szallasi,et al.  Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers , 2014, European urology.

[3]  D. Lindgren,et al.  The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. , 2014, European journal of cancer.

[4]  N. Lou,et al.  miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes , 2014, Journal of Cancer Research and Clinical Oncology.

[5]  Dae-Ho Lee,et al.  Active surveillance for metastatic or recurrent renal cell carcinoma , 2014, Journal of Cancer Research and Clinical Oncology.

[6]  Karthik Devarajan,et al.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC , 2014, Cancer biology & therapy.

[7]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[8]  L. Antunes,et al.  MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis , 2013, British Journal of Cancer.

[9]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[10]  C. Norbury,et al.  The Long and Short of MicroRNA , 2013, Cell.

[11]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[12]  E. Maher.  Genomics and epigenomics of renal cell carcinoma. , 2013, Seminars in cancer biology.

[13]  A. Lund,et al.  MicroRNA and cancer , 2012, Molecular oncology.

[14]  T. Thum,et al.  Circulating and urinary microRNAs in kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[15]  Jelle J. Goeman,et al.  Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep Sequencing , 2012, PloS one.

[16]  C. Croce,et al.  microRNA involvement in human cancer. , 2012, Carcinogenesis.

[17]  Ying Sun,et al.  Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. , 2012, The Lancet. Oncology.

[18]  R. Figlin,et al.  Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis , 2012, PloS one.

[19]  M. Esteller,et al.  Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.

[20]  Yasutoshi Yamada,et al.  Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma , 2012, Oncotarget.

[21]  Jörg Grigull,et al.  miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. , 2011, The Journal of urology.

[22]  Antonio Alcaraz,et al.  MicroRNA in prostate, bladder, and kidney cancer: a systematic review. , 2011, European urology.

[23]  J. Gu,et al.  Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma , 2010, Oncogene.

[24]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[25]  Í. Lopes-Cendes,et al.  MicroRNAs: a new paradigm on molecular urological oncology. , 2010, Urology.

[26]  Jean-Jacques Patard,et al.  EAU guidelines on renal cell carcinoma: the 2010 update. , 2010, European urology.

[27]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[28]  M. Nickerson,et al.  MicroRNA-23b* targets proline oxidase, a mitochondrial tumor suppressor protein in renal cancer , 2010, Oncogene.

[29]  Yurong Fu,et al.  Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues , 2010, Journal of Cancer Research and Clinical Oncology.

[30]  Huiqing Liu,et al.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma , 2010, BMC Systems Biology.

[31]  G. Bhanot,et al.  Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.

[32]  A. Lopez‐Beltran,et al.  2009 update on the classification of renal epithelial tumors in adults , 2009, International journal of urology : official journal of the Japanese Urological Association.

[33]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[34]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[35]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[36]  Yingdong Zhao,et al.  BRB-ArrayTools Data Archive for Human Cancer Gene Expression: A Unique and Efficient Data Sharing Resource , 2008, Cancer informatics.

[37]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[38]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[39]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[40]  Ash A. Alizadeh,et al.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.

[41]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[42]  Antonio Lopez-Beltran,et al.  Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. , 2015, European urology.

[43]  O. Slabý,et al.  Urine microRNAs as potential noninvasive biomarkers in urologic cancers. , 2014, Urologic oncology.

[44]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.